Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease.
Journal: The journal of prevention of Alzheimer's disease
Published: January 03, 2025
Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.
Journal: Nature medicine
Published: April 12, 2024
Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 07, 2021
Showing 1-3 of 3
Last Updated: 09/26/2026